Olema Pharmaceuticals, Inc. (OLMA) Tops Q4 EPS by 13c

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q4 EPS of ($0.51), $0.13 better than the analyst estimate of ($0.64).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results